Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Find trials by country, state, or city

Search by locations

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “United States”

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or OverweightRecruiting
NCT07353931Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Osteoarthritis · Overweight or Obesity
United States, Argentina, Belgium, Brazil, Canada +9 more
Pediatric Long-Term Follow-up and Rollover StudyActive Not Recruiting
NCT03975829Phase 4Updated Aug 21, 2026
Sponsor: Novartis Pharmaceuticals
Diffuse Astrocytoma · Anaplastic Astrocytoma · Astrocytoma · Oligodendroglioma, Childhood
United States, Argentina, Australia, Belgium, Brazil +14 more
Well-Mama Community Doula Navigator StudyActive Not Recruiting
NCT05179369NAUpdated Aug 21, 2026
Sponsor: Northwestern University
Pregnancy Related
United States
Copanlisib and Nivolumab in Treating Patients With Richter's Transformation or Transformed Indolent Non-Hodgkin LymphomaActive Not Recruiting
NCT03884998Phase 1Updated Aug 21, 2026
Sponsor: City of Hope Medical Center
Chronic Lymphocytic Leukemia · Diffuse Large B-Cell Lymphoma · Follicular Lymphoma · Indolent Non-Hodgkin Lymphoma
United States
Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability up to 6 Years of Intravenous (i.v.) Secukinumab in Pediatric Participants With Juvenile Psoriatic Arthritis (JPsA).Recruiting
NCT06751238Phase 1Updated Aug 21, 2026
Sponsor: Novartis Pharmaceuticals
Juvenile Psoriatic Arthritis
United States
Phase 3 Trial of VMX-C001 vs Usual Pharmacological Care in Patients Taking a FXa Direct Oral Anticoagulant Who Require Urgent Surgery With or Without Heparin.Recruiting
NCT07288489Phase 3Updated Aug 21, 2026
Sponsor: VarmX B.V.
Blood Loss, Surgical · Coagulation Disorder
United States, Australia, Bulgaria, France, Japan +2 more
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIVRecruiting
NCT07698600Phase 1Updated Aug 21, 2026
Sponsor: BioNTech SE
HIV -1 Infection
United States
Mild Cognitive Impairment and NeuromodulationEnrolling By Invitation
NCT07691918NAUpdated Aug 21, 2026
Sponsor: Virginia Polytechnic Institute and State University
Mild Cognitive Impairment (MCI)
United States
A Study to Compare Standard Therapy to Treat Hodgkin Lymphoma to the Use of Two Drugs, Brentuximab Vedotin and NivolumabRecruiting
NCT05675410Phase 3Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
United States, Canada, Puerto Rico
A Study to Evaluate the Drug Levels, Absolute Bioavailability, Safety, Tolerability, and Immunogenicity of Single-Dose of BMS-986446 in Healthy Adults After Single-dose Administration, and Participants With Early Alzheimer's Disease After Multiple Dose AdministrationNot Yet Recruiting
NCT07780383Phase 1Updated Aug 21, 2026
Sponsor: Bristol-Myers Squibb
Alzheimer's Disease · Healthy Participants
United States
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 DiabetesRecruiting
NCT07282600Phase 3Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Overweight · Obesity
United States, Argentina, China, Czechia, Germany +9 more
Screening for Social Determinants of Health (SDOH) and Cognitive Function in Individuals With History of StrokeRecruiting
NCT06615973N/AUpdated Aug 21, 2026
Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)
Stroke · Brain Disease · Vascular Diseases · Cerebrovascular Disorder
United States
A Phase 2b Study to Evaluate Rezpegaldesleukin (Rezpeg) in the Treatment of Adult Patients With Moderate-to-Severe Atopic DermatitisActive Not Recruiting
NCT06136741Phase 2Updated Aug 21, 2026
Sponsor: Nektar Therapeutics
Moderate to Severe Atopic Dermatitis
United States, Australia, Bulgaria, Canada, Croatia +5 more
Clinical Outcomes After Treatment of Distal Humerus Fractures With the LORRAINE 2.5/3.5 mm Distal Humerus SystemNot Yet Recruiting
NCT07774091N/AUpdated Aug 21, 2026
Sponsor: Bonebridge AG
Intra-Articular or Extra-Articular Distal Humerus Fracture · Distal Humerus Fracture
United States
Exploratory Study for Toivoa-001 on Human FactorsCompleted
NCT06477913NAUpdated Aug 21, 2026
Sponsor: Toivoa Inc
Anxiety Depression · Disability Physical
United States
LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have CirrhosisRecruiting
NCT06632457Phase 3Updated Aug 21, 2026
Sponsor: Boehringer Ingelheim
Metabolic Dysfunction Associated Steatohepatitis
United States, Argentina, Australia, Austria, Belgium +31 more
A Study to Evaluate the Efficacy and Safety of Maintenance Ublituximab Following Induction With Efgartigimod Administration in Participants With Myasthenia Gravis (MG)Recruiting
NCT07673744Phase 2Updated Aug 21, 2026
Sponsor: TG Therapeutics, Inc.
Myasthenia Gravis
United States
Study of Preoperative Radiation Therapy in Participants With Resectable Recurrent Abdominal Adrenocortical CarcinomaRecruiting
NCT06487481Phase 1Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Adrenocortical Carcinoma (ACC) · Recurrent Adrenocortical Carcinoma (ACC) · Recurrent Abdominal Adrenocortical Carcinoma (ACC) · Carcinoma, Adrenocortical
United States
Palbociclib and Binimetinib in RAS-Mutant Cancers, A ComboMATCH Treatment TrialActive Not Recruiting
NCT05554367Phase 2Updated Aug 21, 2026
Sponsor: National Cancer Institute (NCI)
Exocrine Pancreas Carcinoma · Malignant Solid Neoplasm · Ovarian Low Grade Serous Adenocarcinoma · Stage IV Ovarian Cancer AJCC v8
United States, Puerto Rico
A Phase 1, Open-Label, Dose-Escalation Study to Evaluate Safety, Tolerability, and Clinical Activity of CBX-663 in Participants With Relapsed or Refractory Myeloid Malignancies, Advanced Solid Tumors, or Recurrent or Progressive Glioblastoma.Not Yet Recruiting
NCT07779798Phase 1Updated Aug 21, 2026
Sponsor: Crossbow Therapeutics, Inc.
Advanced Solid Tumors · Recurrent or Progressive Glioblastoma · Relapse or Refractory Myeloid Malignancies
United States
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin ActionRecruiting
NCT05414409Phase 2Updated Aug 21, 2026
Sponsor: Heba M. Ismail
Type 1 Diabetes · Obesity
United States
LY4268989 in Adults With Moderately to Severely Active Ulcerative ColitisRecruiting
NCT07415044Phase 2Updated Aug 21, 2026
Sponsor: Eli Lilly and Company
Ulcerative Colitis (UC) · Ulcerative Colitis, Active Moderate · Ulcerative Colitis, Active Severe
United States, Argentina, Brazil, Canada, China +23 more
An Open-Label Phase 2 Study of N-Acetyl-D-Mannosamine (ManNAc) in Subjects With Primary Focal Segmental GlomerulosclerosisRecruiting
NCT06664814Phase 2Updated Aug 21, 2026
Sponsor: National Human Genome Research Institute (NHGRI)
Focal Segmental Glomerulosclerosis
United States
Effects of Meal Macronutrients on Postprandial LipidsNot Yet Recruiting
NCT07313787Phase 2Updated Aug 21, 2026
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Nephrotic Syndrome · Lipodystrophy · Metabolic Syndrome · Healthy Volunteer
United States
177Lu-DOTA-EB-TATE in Adult Patients With Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid CancerNot Yet Recruiting
NCT06991738Phase 1, Phase 2Updated Aug 21, 2026
Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Thyroid Cancer
United States

Previous page Next page